Among patients with curatively resected early-stage biliary tract cancer (BTC), recent study findings from a real-world cohort trial revealed the value of circulating tumor DNA (ctDNA) as a prognostic ...

ctDNA offers a non-invasive way to track Multiple Myeloma, reducing the need for painful bone marrow biopsies Detects genetic mutations, treatment resistance, and disease progression before ...

circulating tumor DNA (ctDNA), which is released into the bloodstream by tumor cells, offers a promising non-invasive alternative. It allows for real-time monitoring and comprehensive genetic ...

Fourier Transform Infrared (FTIR) spectroscopy provides rapid and cost-effective testing of many pharmaceuticals, especially when combined with accessories saving transmission and time.

Natera (NTRA) announced that the U.S. Patent and Trademark Office has issued Natera a new patent related to testing of single nucleotide variants in circulating-tumor DNA or ctDNA. This builds on ...

New findings of the Stratified Medicine Paediatrics (SMPaeds1) programme, published in the journal Cancer Discovery, have successfully demonstrated that circulating tumour DNA (ctDNA) testing can be ...

I know a lot of you see a lot of patients with lung cancer, so in a scenario like this, would you consider doing any sort of circulating tumor DNA [ctDNA] assay or any other element that would help ...

A NEW STUDY has demonstrated the clinical utility of circulating tumour DNA (ctDNA) analysis as an alternative to tissue biopsy for genotyping in advanced urothelial cancer (UC). Researchers aimed to ...

Employing PhasED-Seq technology, the test is a circulating tumour DNA (ctDNA)-based minimal residual disease (MRD) LDT. The trial aims to evaluate the possibility of decreasing chemotherapy exposure ...